Funding Opportunities

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The Advancing Craniosynostosis Treatment (ACT) Rare Diseases Consortium invites proposals for pilot research projects focused on advancing diagnosis, clinical trial readiness, and management and treatment of syndromic craniosynostosis. This pilot funding opportunity is intended to support early-stage, high-impact projects that generate preliminary data, validate novel concepts, or de-risk innovative approaches with strong potential for downstream translational, clinical, or commercialization impact. Projects supported through this pilot program should align with the broader mission of the ACT Rare Diseases Consortium and complement and/or expand upon the research activities of Clinical Project 1, Clinical Project 2, and Clinical Project 3.

Sponsor: Advancing Craniosynostosis Treatment (ACT) Rare Disease

Eligibility Criteria: The PI must be based at a US-based academic institution or research institution. The PI must hold a doctoral-level degree or be enrolled in a doctoral-level program.

Application Due Date: 2026-04-15

Term: 12 months